All Pharma News
IPAB stays revocation of Pharmacyclics’ patent on anti-cancer drug Ibrutinib

IPAB stays revocation of Pharmacyclics’ patent on anti-cancer drug Ibrutinib
PHARMABIZ
23 Jun 2020
Share Share
Patent for Pharmacyclic`s cancer drug revoked on challenge by Laurus Labs

Patent for Pharmacyclic`s cancer drug revoked on challenge by Laurus Labs
Gireesh Babu BUSINESS-STANDARD
23 Mar 2020
Share Share
Swiss biotech ADC Therapeutics guns for $150M IPO

Swiss biotech ADC Therapeutics guns for $150M IPO
Ben Adams FIERCEBIOTECH
09 Sep 2019
Share Share
Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS

Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS
Kyle Blankenship FIERCE PHARMA
02 Jul 2019
Share Share
AstraZeneca`s Calquence treads on Imbruvica`s turf with second phase 3 CLL win

AstraZeneca`s Calquence treads on Imbruvica`s turf with second phase 3 CLL win
Carly Helfand FIERCE PHARMA
07 Jun 2019
Share Share
AbbVie unveils Venclexta data

AbbVie unveils Venclexta data
Carly Helfand FIERCE PHARMA
04 Jun 2019
Share Share
Ascentage Pharma Appoints Jeff Kmetz as Chief Business Officer

Ascentage Pharma Appoints Jeff Kmetz as Chief Business Officer
PR NEWSWIRE
15 Feb 2019
Share Share
Imbruvica® (Ibrutinib) : Janssen Biotech vs. Zydus, Cadila Healthcare

Imbruvica® (Ibrutinib) : Janssen Biotech vs. Zydus, Cadila Healthcare
PATENT LITIGATION
29 Jan 2019
Share Share
Cerdelga (eliglustat) : Genzyme vs. Cipla Ltd.

Cerdelga (eliglustat) : Genzyme vs. Cipla Ltd.
PATENT LITIGATION
24 Nov 2018
Share Share
Imbruvica (ibrutinib): Pharmacyclics, Janssen Biotech vs. Hetero Labs

Imbruvica (ibrutinib): Pharmacyclics, Janssen Biotech vs. Hetero Labs
PATENT LITIGATION
24 Nov 2018
Share Share